GRANULES INDIA LIMITED

Granules India Limited (Singapore) is primarily a trading and distribution entity. While its parent company, Granules India Limited, is a prominent pharmaceutical manufacturer based in India, the Singapore office typically functions as a regional hub for sales, marketing, and distribution of the pharmaceutical products manufactured by its parent company. It is not a manufacturing facility itself.

Company Profile:

Name: Granules India Limited (Singapore)

Nature of Business (in Singapore):

The Singapore entity of Granules India Limited serves as a key regional office, primarily engaged in the sales, marketing, and distribution of Active Pharmaceutical Ingredients (APIs), Pharmaceutical Formulation Intermediates (PFIs), and Finished Dosages (FDs) manufactured by its parent company in India. It plays a crucial role in expanding Granules India Limited's global footprint and managing its supply chain within the Asia-Pacific region.

Parent Company:

Granules India Limited, headquartered in Hyderabad, India, is a vertically integrated pharmaceutical company. It is a leading manufacturer of APIs, PFIs, and FDs, serving both regulated and semi-regulated markets worldwide. The company is known for its focus on quality, cost-effectiveness, and efficient manufacturing processes.

Key Activities (Singapore):

Regional sales and marketing operations

Distribution and logistics management

Business development and strategic partnerships

Customer support for the region

This Singapore presence underscores Granules India Limited's commitment to international markets and its strategy for efficient product delivery and market penetration.

GRANULES INDIA LIMITED in Singapore primarily focuses on the sale and distribution of a broad portfolio of pharmaceutical products. These products are generally categorized into:

Active Pharmaceutical Ingredients (APIs)

These are the primary active components of pharmaceutical drugs. Key APIs include:

Paracetamol (Acetaminophen)

Ibuprofen

Metformin Hydrochloride

Guaifenesin

Methocarbamol

Naproxen

Fexofenadine Hydrochloride

Ranitidine Hydrochloride

Pharmaceutical Formulation Intermediates (PFIs)

These are pre-formulated mixtures of APIs and excipients, ready for compression into tablets or filling into capsules, simplifying the manufacturing process for their clients. Examples include:

Paracetamol PFI

Ibuprofen PFI

Metformin PFI

Finished Dosages (FDs)

These are final pharmaceutical products like tablets and capsules, ready for patient consumption. Granules India Limited offers a range of generic finished dosages across various therapeutic categories. These include:

Analgesics

Anti-inflammatories

Antidiabetics

Muscle relaxants

Antihistamines

Gastrointestinal drugs